Drug Profile


Alternative Names: Azarga; Elazop; Timolol/brinzolamide

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alcon
  • Class Amino alcohols; Antiglaucomas; Morpholines; Propanolamines; Sulfonamides; Thiadiazoles; Thiazines
  • Mechanism of Action Beta-adrenergic receptor antagonists; Carbonic anhydrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Glaucoma; Ocular hypertension

Most Recent Events

  • 06 Sep 2016 No recent reports on development identified - Phase-III for Glaucoma and Ocular hypertension in USA (Ophthalmic)
  • 17 Apr 2013 Launched for Glaucoma in Malaysia, Singapore, Thailand, Taiwan and South Korea (Ophthalmic) prior to April 2013
  • 17 Apr 2013 Launched for Ocular hypertension in Malaysia Singapore, Thailand, Taiwan and South Korea (Ophthalmic) prior to April 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top